Fields & Applications Sample Preparation, Spectroscopy, Mass Spectrometry, Microscopy, Sensors, Technology, Data Analysis, Pharma & Biopharma, Materials, Clinical

Detecting agglomerates within pharmaceutical formulations

Particle agglomeration can compromise the clinical efficacy of pharmaceutical products and must therefore be closely controlled. Automated particle image analysis provides one technology which can aid agglomerate detection. This article provides practical guidance on how imaging can be applied as a routine method to robustly identify and quantify the state of agglomeration of pharmaceutical formulations.

05/28/2015

A new article from Malvern Instruments provides practical guidance on using automated particle image analysis to detect agglomerates in pharmaceutical formulations. Particle agglomeration has the potential to compromise clinical efficacy and must therefore be closely monitored and controlled during manufacture. Experimental data illustrate different strategies for the detection of agglomerates on the basis of size, shape and, where necessary, chemical identification. Compared with manual microscopy, automated imaging is fast, statistically reliable and cost efficient, making it a valuable tool for product development, process troubleshooting and QC.

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

Receive communication from The Cannabis Scientist I want to stay up to date with the Mass Spectrometry field I want to stay up to date with the Spectroscopy field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.